Felix Fennemann, PhD

Felix Fennemann, PhD has a diverse work experience. Starting in 2005, they completed a Researcher Internship at Geologischer Dienst NRW. In 2008, they completed a Researcher Internship at IWW Microbiology. In 2010, they completed a Researcher Internship at Fremantle Dermatology and also worked as a Male Nurse at St. Marienhospital. From 2014 to 2015, they worked as a Research Trainee in Tumor Immunology at RIMLS. In 2015, they worked as a Research Trainee in Immunotherapy at the Cancer Center Karolinska. From 2016 to 2020, they were a PhD Candidate at the Radboud Institute for Molecular Life Sciences (RIMLS). In 2018, they became the Chair of the ENABLE 2019 Scientific Organizing Committee, a project funded by an EU Horizon 2020 grant. Currently, they work as a Scientist in Immunology and Cell Biology at Lava Therapeutics B.V.

Felix Fennemann, PhD has an education history that includes a Bachelor of Applied Science (BASc) in Medical Biology from Radboud University from 2011 to 2014, a Master of Science (MSc) in Molecular mechanisms of disease from Radboud University from 2014 to 2016, and Honours Beyond Frontiers from Radboud University from 2015 to 2016.